Pharmacopsychiatry

Papers
(The TQCC of Pharmacopsychiatry is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
187
SARS-CoV-2-Infection in People Addicted to Illegal Drugs – Is There a Protective Effect of Opioid Maintenance Treatment?70
Exposure to Psychotropic Drugs and Colorectal Cancer Risk in Patients with Affective Disorder: A Nested Case-Control Study26
Challenges Related to the Implementation of Measurement-Based Care for the Treatment of Major Depressive Disorder: A Feasibility Study24
The Role of Circadian Rhythmicity and CLOCK Genes in Psychiatry22
Time-Dependent Effects of Metformin and Olanzapine on the Metabolic System21
Twenty-Three Years of Declining Lithium Use: Analysis of a Pharmacoepidemiological Dataset from German-Speaking Countries20
2001–2021 Comparative Persistence of Oral Antipsychotics in Patients Initiating Treatment: Superiority of Clozapine in Time-to-Treatment Discontinuation18
Case series: Higher antipsychotic drug levels in patients with schizophrenia after COVID-19 vaccination16
Effects of a citalopram treatment on the amyloid-β-pathology and behaviour in the 5xFAD Alzheimer mouse model16
Neuronal Correlates of Delusional Symptomatology in Affective and Psychotic Disorders15
The Endocannabinoid System in PTSD: Molecular Targets for Modulating Fear and Anxiety15
The Role of Mood Stabilizers in Children and Adolescents with Anorexia Nervosa: A 1-year Follow-Up, Propensity Score-Matched Study13
The Mini-TRH Test13
Neutral sphingomyelinase is a major driver of sex-differences in depression and alcohol-abuse10
Psychiatric syndromes associated with anti-neural autoantibodies differ in their affective psychopathology from those that are not10
CircRNAs in Peripheral Blood: Potential Biomarkers for Alzheimer’s Disease?9
Predicting mental health symptoms with NBS-Predict8
Recreational Cannabis Legalization: No Contribution to Rising Prescription Stimulants in the USA7
Epigenetics for Drug Discovery: Dissecting the Effect of High Antipsychotic Dosage and D2 Blockage on Peripheral DNA Methylation7
7
GABAergic Effects of Etifoxine and Alprazolam Assessed by Double Pulse TMS7
Mineralocorticoid and glutamatergic NMDA receptor stimulation does not influence spatial learning and memory in depressed individuals and healthy control6
Amphiphysin und GAD65 IgG Antikörper bei Zwangsstörungen6
6
News on the Role of Antidepressants in and for COVID-19 and Long COVID6
6
Effects of Pharmacokinetic Gene Variation on Therapeutic Drug Levels and Antidepressant Treatment Response6
POMC and NR3C1-1F DNA methylation in major depressive disorder and electroconvulsive therapy6
Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes5
Patient and Physician Exposure to Artificial Intelligence Hype5
Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factor5
Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey5
Current data from the AMSP Project on the risk of treatment with antidepressants and antipsychotics within the clinical setting5
5
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie5
4
Bariatric surgery: impact on oral aripiprazole and fluoxetine bioavailability – A clinical case4
Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis4
Impaired nonverbal communication is associated with symptom severity in Depression4
4
Vitamin D: Adjustment of Per1 expression in study participants with an ADHD diagnosis4
Effects of Anesthesia Changes During Maintenance ECT: A Longitudinal Comparison of Seizure Quality Under Anesthesia Using Propofol/Esketamine Versus Methohexita4
3
Linkage of Young Mania Rating Scale to Clinical Global Impression Scale to Enhance Utility in Clinical Practice and Research Trials3
Increased Odds of Cognitive Impairment in Adults with Depressive Symptoms and Antidepressant Use3
Perceptions, Experiences, and Patterns of Cannabis Use in Individuals with Mood and Anxiety Disorders in the Context of Cannabis Legalization and Medical Cannab3
Clinical Outcomes after Clozapine Discontinuation in Patients with Schizophrenia: A Systematic Review3
Longitudinal Multimodal Analysis of Structural Brain Changes and Psychopathology Using Data-Driven Fusion Approaches3
Therapeutic drug monitoring of sertraline in pediatric population: A naturalistic study with insights into the clinical response of obsessive-compulsive disorde3
Does Lidocaine Shorten Seizure Duration in Electroconvulsive Therapy?2
Pharmacological Treatment of Early-Onset Schizophrenia: A Critical Review, Evidence-Based Clinical Guidance and Unmet Needs2
Impact of Antipsychotic Medications on Weight Gain and Eating Disorder-Related Psychopathology in Adult Inpatients with Anorexia Nervosa2
Monitoring Anesthetic Depth Using the Patient State Index in Electroconvulsive Therapy Improves Seizure Quality2
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics2
Cardiovascular Effects of Non-Selective Monoamine Oxidase Inhibitors and Intranasal Esketamine Combination in Depression – A Quasi-Experimental Design with Baye2
Revisiting the World’s Strictest COVID-19 Lockdown: Formidable Mental Health Challenges2
Das therapeutische Potential von niedrig dosiertem Δ9-Tetrahydrocannabinol bei der Modulation der Alzheimer-Pathologie im 5xFAD-Mausmodell2
Overview: Chronic Pain and Cannabis-Based Medicines2
A retrospective comparison of etomidate and methohexital as anesthetic agents for maintenance electroconvulsive therapy2
Metformin is Protective Against the Development of Mood Disorders2
1
Investigating the role of CCL11 in shaping microglial age-and long-COVID-related inflammatory activation1
Ausschreibung Peter Müller Preis für Forschung im Bereich Schizophrenie1
Development of a Genetic Test Indicating Increased AVP/V1b Signalling in Patients with Acute Depression1
How valid are therapeutic reference ranges for psychotropic drugs?1
Investigation of Stress-Induced Cortisol Effects on Decision Making After Pharmacological Mineralocorticoid or Glucocorticoid Receptor Blockade1
1
Brain Fog reconsidered. Objectifying subjective cognitive impairment following COVID-19 infection.1
Reward System in Schizophrenia: Characterizing Clinical and Neurobiological Underpinnings with Regard to Sexuality1
QTc interval alterations during antidepressant treatment with escitalopram and venlafaxine1
In major depression early response to antidepressant treatment in week one is associated with FKBP5-gene variants rs1360780 and rs47139161
Functional connectivity analysis of locus coeruleus in patients with major depressive episode1
Predicting one-year postoperative cognitive dysfunction after cardiac surgery by combining markers of amyloid-β and tau pathology1
Major depressive episodes with high rapid eye movement density do not respond better to rapid eye movement sleep suppressive antidepressants than to others1
Factors Associated with Antidepressant Effects of Ketamine: A Reanalysis of Double-Blind Randomized Placebo-Controlled Trial of Intravenous Ketamine for Treatme1
Glycine and the ketamine model of schizophrenia: Modulating the N-methyl-D-aspartate receptor (NMDAR) offers new insights into the glutamate hypothesis of schiz1
1
0.052119016647339